← Back to Search

Platelet-rich plasma (PRP)

Platelet-rich plasma (PRP) for Osteoarthritis

Phase 4
Waitlist Available
Led By Moin Khan, FRCSC
Research Sponsored by ArthroBiologix Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

Study Summary

This trial will test whether patients who watch the steps involved in their PRP injection for knee arthritis have better outcomes than those who don't.

Eligible Conditions
  • Osteoarthritis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
VAS Pain
Secondary outcome measures
Range of motion
Short Form 12 (SF-12) Functional outcome assessment
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Viewing of preparationExperimental Treatment2 Interventions
The patient will be in the room for the preparation of the PRP and will receive a description of the centrifuge process from the physician administering the injection.
Group II: Blinded to preparationPlacebo Group1 Intervention
The patient will leave the room after their blood is drawn and will not view the preparation of the PRP, and will also not receive a description of the centrifuge process.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Platelet-rich plasma (PRP)
2009
Completed Early Phase 1
~10

Find a Location

Who is running the clinical trial?

ArthroBiologix Inc.Lead Sponsor
Moin Khan, FRCSCPrincipal InvestigatorMcMaster University
1 Previous Clinical Trials
200 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~29 spots leftby Apr 2025